Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An update from FOXO Technologies ( (FOXO) ) is now available.
FOXO Technologies Inc. announced that it has regained compliance with NYSE American’s continued listing requirements by increasing its stockholders’ equity to over $4 million through recent transactions. The company achieved this by exchanging debt for equity involving various stakeholders and aims to eliminate the risk of delisting, enhancing its stability and commitment to shareholder growth.
More about FOXO Technologies
FOXO Technologies Inc. operates in the biotechnology industry and focuses on improving human health and life span through innovative technology and product solutions. It owns and operates three subsidiaries, including Foxo Labs, Inc., a biotechnology company, Myrtle Recovery Centers, Inc., a behavioral health facility, and Rennova Community Health, Inc., which operates a hospital in East Tennessee.
YTD Price Performance: 41.07%
Average Trading Volume: 48,620,136
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.86M
For an in-depth examination of FOXO stock, go to TipRanks’ Stock Analysis page.
